SigmaGraft
CA - FullertonBiotechnology
Focus: SigmaGraft is a public-stage biotechnology company focused on bone substitutes, wound dressings, and resorbable membranes for orthopedic and musculoskeletal applications. The company operates in a specialized niche within regenerative medicine and orthopedics.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About SigmaGraft
AI assessmentNot HiringNo open roles listed right now. Follow SigmaGraft to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
InterOss Collagen
Early Development
Lead program targeting peri-implantitis, a significant unmet need in implant dentistry and orthopedics with 1 active trial.
Pipeline & Clinical Trials
InterOss Collagen
Peri-ImplantitisHelp build intelligence for SigmaGraft
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.